ArticleNature communications2026
CenSegNet: a generalist high-throughput deep learning framework for centrosome phenotyping at spatial and single-cell resolution in heterogeneous tissues.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Centrosome abnormalities (CA) are a hallmark of epithelial cancers, yet their spatial complexity and phenotypic heterogeneity remain poorly understood due to limitations in conventional image analysis. Here we present CenSegNet (Centrosome Segmentation Network), a modular deep learning framework for high-throughput segmentation of centrosomes and epithelial architecture, enabling accurate and generalisable centrosome phenotyping at spatial and single-cell resolution across imaging modalities and tissue contexts. Applied to tissue microarrays comprising 911 breast cancer cores from 127 patients, CenSegNet enables large-scale, spatially resolved quantification of numerical and structural CA. We show that these CA subtypes are mechanistically uncoupled, exhibiting distinct spatial distributions, age-dependent dynamics, and associations with tumour grade, hormone receptor status, genomic alterations and nodal involvement. Structural CA are associated with overall survival, whereas discordant CA profiles at tumour margins correlate with local tumour aggressiveness and stromal remodelling. These findings establish CenSegNet as a scalable platform for spatially resolved centrosome phenotyping, enabling systematic investigation of centrosome biology and its dysregulation in cancer and other epithelial diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.